Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 264 results found. Search for [ COVID-19 vaccine trials China ]

Results 160 to 180 of 264
BusinessToday.In
July 17, 2020
Coronavirus vaccine: The human trial of COVAXIN has started in All India Institute of Medical Sciences in Patna and Post-Graduate Institute of Medical Sciences in Rohtak


BusinessToday.In
New Delhi, July 16, 2020
Google to invest Rs 33,737 crore in Jio PlatformsMukesh Ambani, during the Reliance Industries Annual General Meeting on Wednesday announced that Google would invest Rs 33,737 crore in Jio Platforms. Google is the latest tech giant to invest in Jio Platforms after Facebook, Qualcomm and Intel. Google's is the 14th investment since April 22 amounting to a total of Rs 152,055.45 crore.Decision on Tiktok, Chinese apps likely in weeks, not months: White HouseThe White House indicated on Wednes...


BusinessToday.In
New Delhi, July 15, 2020
US President Donald Trump  expressed anger over China's inability to prevent the spread of the coronavirus out of the country, from where it originated; Britain's government on Tuesday backtracked on plans to give Chinese telecommunications company Huawei a limited role in the UK's new high-speed mobile phone network; As the world vies to develop a coronavirus vaccine, human trials for Bharat Biotech' Covaxin began at All India Institute of Medical Sciences (AIIMS) in Patna. Watch this and more on News Blast.Also Read: Coronavirus vaccine: Zydus Cadila, Bharat Biotech start trials; Moderna enters final phase


Associated Press
July 15, 2020
There were no serious side effects. But more than half the study participants reported flu-like reactions to the shots that aren't uncommon with other vaccines -- fatigue, headache, chills, fever and pain at the injection site


BusinessToday.In
New Delhi, July 15, 2020
Coronavirus: Moderna early stage trials prove experimental vaccine safeModerna Inc's experimental vaccine for COVID-19 showed it was safe and provoked immune responses in all 45 healthy volunteers in an ongoing early-stage study, U.S. researchers reported on Tuesday. Volunteers who got two doses of the vaccine had high levels of virus-killing antibodies that exceeded the average levels seen in people who had recovered from COVID-19, the team reported in the New England Journal of Medicine.Roa...


BusinessToday.In
July 15, 2020
Stock Market Highlights on July 15: Infosys, Axis Bank, Tech Mahindra, Bajaj Finance, Tata Steel, HCL Tech and IndusInd Bank were among the other gainers on Sensex. On the other hand, Bharti Airtel, ITC and Kotak Bank were the laggards


BusinessToday.In
July 13, 2020
The Sechenov First Moscow State Medical University said that clinical trial began on June 18. The university added that it conducted human trials on a group of 38 volunteers in two batches


BusinessToday.In
July 13, 2020
Bharat Biotech is developing the vaccine in collaboration with the ICMR. It has started human trials on its vaccine candidate, 'Covaxin', which is India's first indigenous COVID-19 vaccine. It is working to develop an initial capacity of 200 million vials of the vaccine


Reuters
July 13, 2020
Thailand's first facility should complete production in October and send the products to a second facility, which should finish by November


Reuters
July 12, 2020
Coronavirus vaccine news update: China's success in driving down COVID-19 infections has made it harder to conduct large-scale vaccine trials, and so far only a few countries have agreed to work with it


PTI
July 7, 2020
They will give the green signal. Then the medicine people will examine and the first shot of the vaccine will be given due observation,\" NIMS director Dr K Manohar told


Reuters
July 7, 2020
Sinovac said the study, which will be done in partnership with Brazilian vaccine producer the Instituto Butantan, would recruit nearly 9,000 healthcare professionals working in COVID-19 specialised facilities and start this month


BusinessToday.In
July 6, 2020
Coronavirus vaccine: AIIMS in Delhi and Patna are among the 12 institutes selected to conduct the clinical trials for Covaxin


BusinessToday.In
July 6, 2020
Stock Market LIVE Updates on July 6: HDFC Bank, IndusInd Bank, IT, Bajaj Finance and NTPC were among the top gainers today while HUL and Bajaj Auto were among the losers.


Rupa Burman Roy
July 5, 2020
Stock Market in the upcoming week: Besides tracking global cues, investors are also expecting that RBI may unveil more relief measures for some of the stressed sectors of the economy to help them emerge from the bruising impact of the lockdown


PTI
July 5, 2020
Domestic equity indices advanced for the third straight day to close near four-month highs on Friday. During the last week, the BSE Sensex rallied 850.15 points or 2.41 per cent


BusinessToday.In
New Delhi, July 3, 2020
Catch top stories from the world of business and economy with BusinessToday.In's Biz EOD report


Ashish Pandey
July 3, 2020
After 20 soldiers were killed in border clashes, India has resorted to what increasingly looks like a trade war with China, targeting Chinese companies and projects in India 


BusinessToday.In
July 3, 2020
Stock Market LIVE Updates on July 3: Bajaj Auto, followed by Asian Paints, Bharti Airtel, HUL, Reliance Industries, HUL and Kotak Bank were among the top gainers in the Sensex pack. On the contrary, Tata Steel, HDFC, M&M and Bajaj Finance were among the laggards


Rupa Burman Roy
July 2, 2020
The COVID-19 vaccines developed by German biotech firm BioNTech and the US pharmaceutical giant Pfizer have shown potential and was found to be well tolerated in early-stage human trials testing of 45 people


PAGES 9 OF 14  678910